HNGE — Hinge Health Inc. price, chart and key statistics

Price data

Price

$99.16

YTD price return

+113.48%

YTD total return

+113.48%

Next earnings

Nov 2, 2026 · After close

Market cap

8B2025-06 2.3B2026-10 8B+251.9% over the window

Enterprise value

7.5B

Shares outstanding

80.7M2025-06 43.9M2026-06 80.7M+83.7% over the window

52W low

$30.08

52W high

$107.00

From 52W high

-7.33%

From 52W low

+229.65%

52W range

90%

Volume

Rel volume

0.94×

30D volume

1.8M

30D $ vol

174.5M

Fundamentals

Sales (ttm)

720.1M2023-12 292.7M2026-06 720.1M+146.0% over the window

Sales/share

$8.922024-12 $8.892026-06 $8.92+0.4% over the window

EPS (ttm)

$1.342023-12 -$8.312026-06 $1.34-116.2% over the window

FCF (ttm)

290.1M2023-12 -65.9M2026-06 290.1M-540.3% over the window

FCF/share

$3.602024-12 $1.092026-06 $3.60+229.3% over the window

Book value/share

$4.272024-12 -$9.892026-06 $4.27-143.1% over the window

Net margin

15.15%2023-12 -36.9%2026-06 15.1%-141.0% over the window

ROE

31.68%2025-06 -305.6%2026-06 31.7%-110.4% over the window

ROA

13.18%2024-12 -1.8%2026-06 13.2%-843.7% over the window

Current ratio

1.342024-12 2.342026-06 1.34-42.9% over the window

Growth (CAGR, ttm) · 10Y

Sales

+49.81%2025-06-30 → 2026-06-30480.8M → 720.1M (+49.8% total)+43.40%2023-12-31 → 2026-06-30292.7M → 720.1M (+146.0% total)n/an/a

FCF

+218.48%2025-06-30 → 2026-06-3091.2M → 290.1M (+218.2% total)n/an/an/a

Shares

+83.76%2025-06-30 → 2026-06-3043.9M → 80.7M (+83.7% total)n/an/an/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

-18.48%2025-06-30 → 2026-06-30$10.94 → $8.92 (-18.5% total)n/an/an/a

FCF/share

+73.31%2025-06-30 → 2026-06-30$2.08 → $3.60 (+73.2% total)n/an/an/a

Book value/share

+7.88%2025-06-30 → 2026-06-30$3.96 → $4.27 (+7.9% total)n/an/an/a

Price

+95.52%2025-10-16 → 2026-10-16$50.74 → $99.16 (+95.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/an/an/a

Total return

+95.52%2025-10-16 → 2026-10-16$50.74 → $99.16 (+95.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/an/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

73.7×2025-06 -4.282026-10 73.35-1813.4% over the window

Fwd P/E

33.7×

P/S (ttm)Market cap ÷ TTM revenue.

11.1×2025-06 4.732026-10 11.11+135.0% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

23.2×2025-06 13.082026-10 23.23+77.6% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

27.6×2025-06 24.942026-10 27.57+10.6% over the window

EV/EBITDA (fy)

76.8×

EV/Sales (ttm)

10.4×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

3.63%2025-06 4.0%2026-06 4.3%+8.0% over the window

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($181.1M) ÷ today's market cap ($8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

2.26%2025-06 0.0%2026-06 2.7%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $181.1M + TTM dividends $0) ÷ today's market cap ($8B). Same caveat as the cash buyback yield.

2.26%2025-06 0.0%2026-06 2.7%